Major paradigm shift incorporates five-year risk assessment and identifies increased-risk women beginning at age 35BOSTON, ...

Now, a significant update to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology is ...

In this segment on advanced renal cell carcinoma, Dr. McGregor focuses on how clinicians move beyond guideline ...

Food - Microbial contamination - ListeriaDistribution: Alberta British Columbia Saskatchewan See the affected products and product photos ...

It couldn’t come at a better time, considering that cancer rates are rising among younger women.

Her career has taken her from treating patients to developing new medicines for biopharma, and now Nancy L. Lewis, MD, MBS, ...

Match Group will release financial results for the first quarter 2026 on Tuesday, May 5, 2026 after-market close. The company will host its quarterly conference call to discuss these results at 5:00 p ...

Dr. Lewis will succeed Dr. Denlinger who previously held the position of CSO before becoming CEO for the organization. Dr. Lewis will assume her new role in May 2026.

Earlier this month, Corcept Therapeutics reported final Phase 3 ROSELLA data showing that Lifyorli (relacorilant) plus nab-paclitaxel improved overall and progression-free survival in adults with ...

Learn how G-CSF and trilaciclib help prevent febrile neutropenia in extensive-stage SCLC, with NCCN-backed timing tips and ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...

Bone-only, osteoblastic disease and the absence of prior ARPI exposure define the optimal radium-223 candidate, while ...